Evidence map›Paper›PMID 24139099›Full record

ArticleTobacco induced diseases2013

Sharp changes in tobacco products affordability and the dynamics of smoking prevalence in various social and income groups in Ukraine in 2008-2012.

Konstantin Krasovsky

Abstract read
In one paragraph

Article in Tobacco induced diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Konstantin KrasovskyInstitute for Strategic Research of the Ministry of Health of Ukraine, Kiev, Ukraine. krasovskyk@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo curb the tobacco epidemic, successful implementation of tobacco control measures should take into account how specific demographic groups react to particular policies. In 2005-2010, Ukraine experienced a sharp decline in smoking prevalence. In 2008-2010, several excise tax hikes combined with the economic recession resulted in a sharp reduction of tobacco product affordability, but in 2011-2012 tax increases were rather moderate. The aim of the current research was to investigate how smoking prevalence in various gender, social and income groups in Ukraine changed in response to differing tobacco taxation policies in 2008-2012.

methodsThe State Statistics Service of Ukraine annual household surveys among the population aged 12 years and older, which include questions about smoking, were used. The aggregate data from the annual household surveys datasets of 2008-2012 were analyzed.

resultsThe decline in general smoking prevalence was much steeper in 2008-2010 - 3.2 percentage points in two years, while in two subsequent years it constituted only 0.6 percentage points. Smoking prevalence declined in all age, social, and income groups in 2008-2010. However, in 2011-2012 smoking prevalence continued to decline mainly among young and poor people, while some older and more affluent smokers apparently relapsed to smoking.

conclusionsShort-term and long-term price responsiveness of tobacco demand by socioeconomic status of population groups in low--and middle--income countries like Ukraine could be rather different for poor and more affluent people. Tobacco excise tax hikes have great potential in reducing smoking prevalence, especially in young and less affluent people, however they should also be supported by effective and available smoking cessation services.

Identifiers

PMID24139099
PMCPMC3853210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.